Spirogen is a biotech company that develops antibody-drug conjugate technology for use in oncology. It specializes in pyrrolobenzodiazepines (PBDs) having a mechanism of action retaining activity against cancer stem cells.
TypeSubsidiary
Founded2000
Websitespirogen.com
Cybersecurity ratingAMore
Spirogen was founded in 2000

Viewing summary data as a guest

Sign up for free to see all data

Spirogen Financials and Metrics

Summary Metrics

Founding Date

2000

Total Funding

$16.4 m

Investors

In total, Spirogen had raised $16.4 m

Spirogen Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Spirogen Online and Social Media Presence

Embed Graph

Spirogen Frequently Asked Questions

  • When was Spirogen founded?

    Spirogen was founded in 2000.

  • Who are Spirogen competitors?

    Competitors of Spirogen include Burzynski Research Institute, Loxo Oncology and Immunomedics.